Q32 Bio (QTTB) Institutional Ownership

$27.13
+0.33 (+1.23%)
(As of 05/10/2024 ET)

Institutional Ownership Changes (13F Filings) for Q32 Bio (NASDAQ:QTTB)

Current
Institutional Ownership
Percentage
31.32%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$63.07M
Number of
Institutional Sellers
(last 12 months)
0
Get QTTB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Q32 Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

QTTB Institutional Buying and Selling by Quarter

Q32 Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024Acadian Asset Management LLC3,695$62K0.0%N/A0.113%
5/10/2024Vanguard Group Inc.107,752$1.84M0.0%N/A3.305%
5/6/2024 Atlas Venture Life Science Advisors LLC2,092,106$35.65M3.3%N/A64.254%
5/3/2024 Carlyle Group Inc.1,102,741$18.07M1.1%N/A33.826%
4/23/2024 BML Capital Management LLC24,894$424K0.3%N/A0.764%
4/22/2024 Vivo Capital LLC370,068$6.31M0.5%N/A11.366%
(Data available from 1/1/2016 forward)

QTTB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of QTTB shares?

During the previous two years, the following institutional investors and hedge funds held shares of Q32 Bio shares: Atlas Venture Life Science Advisors LLC ($35.65M), Carlyle Group Inc. ($18.07M), Vivo Capital LLC ($6.31M), Vanguard Group Inc. ($1.84M), and BML Capital Management LLC ($424K), Acadian Asset Management LLC ($62K).Learn more on QTTB's institutional investors.

What percentage of Q32 Bio stock is owned by institutional investors?

31.32% of Q32 Bio stock is owned by institutional investors. Learn more on QTTB's institutional investor holdings.

Which institutional investors have been buying Q32 Bio stock?

The following institutional investors have purchased Q32 Bio stock in the last 24 months: Atlas Venture Life Science Advisors LLC ($2.09M), Carlyle Group Inc. ($1.10M), Vivo Capital LLC ($370.07K), Vanguard Group Inc. ($107.75K), BML Capital Management LLC ($24.89K), and Acadian Asset Management LLC ($3.70K).

How much institutional buying is happening at Q32 Bio?

Institutional investors have bought a total of 3,701,256 shares in the last 24 months. This purchase volume represents approximately $63.07M in transactions.


This page (NASDAQ:QTTB) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners